Home » Ethicon’s Ablation System Gets Breakthrough Designation
Ethicon’s Ablation System Gets Breakthrough Designation
The FDA has granted Johnson & Johnson subsidiary Ethicon a Breakthrough Device designation for its transbronchial microwave ablation technology with robotic-assisted bronchoscopy.
The designation pairs the NeuWave microwave ablation system with Auris Health’s Monarch platform, a robotic-assisted bronchoscopy system that provides improved access and control.
Ethicon said the combined technologies offer “an exciting opportunity to catalyze new approaches and solutions to improve patient outcomes.”
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May